Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Deficit

v3.24.2
Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock To Be Issued [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance at Mar. 31, 2022 $ 500 $ 67,500 $ 96,701,607 $ 20,132,650 $ 150,036,023 $ (33,133,765)
Balance, shares at Mar. 31, 2022 5,000,000 674,364,124          
Net loss (15,988,020) (15,988,020)
Balance at Mar. 31, 2023 $ 500 $ 80,377 121,156,733 662,767 (56,250) (167,533,292) (45,689,165)
Balance, shares at Mar. 31, 2023 5,000,000 803,123,748          
Net loss (15,602,411) (15,602,411)
Issuance of common shares under financing agreement   $ 21,765 3,146,943 3,168,708
Issuance of common shares under financing agreement, shares   217,655,635          
Shares issued upon exchange of Partitioned Note   $ 3,000 457,000 460,000
Shares issued upon exchange of partitioned note, shares   30,000,000          
 Conversion of Series E Preferred stock to common stock   $ 2,399 825,601 (350,825) 477,175
Conversion of Series E Preferred stock to common stock, shares   23,989,570          
 Accretion of Series E Preferred stock   (27,900) (27,900)
Accretion on Series G Preferred stock   (38,000) (38,000)
 Dividends payable on Preferred stock   (238,728) (238,728)
 Common stock issued to consultants   $ 4,010 600,690 604,700
Common stock issued to consultants, shares   40,100,000          
Common stock issued to employees   $ 75 9,125 9,200
Common stock issued to employees, shares   750,000          
 Common stock issued for legal settlement to NSH shareholders   $ 86 272,657 (272,743)
Common stock issued for legal settlement to NSH shareholders, shares   863,110          
Balance at Mar. 31, 2024 $ 500 $ 111,712 $ 126,468,749 $ 390,024 $ (56,250) $ (183,791,156) $ (56,876,421)
Balance, shares at Mar. 31, 2024 5,000,000 1,116,482,063